LIC MF Healthcare Fund Regular IDCW
Summary Info
Fund Name
: LIC Mutual Fund
Scheme Name
: LIC MF Healthcare Fund Regular IDCW
AMC
: LIC Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 08-Feb-2019
Fund Manager
: Sudhanshu Asthana
Net Assets (Rs. cr)
: 78.3
LIC MF Healthcare Fund Regular IDCW - Nav Details
Nav Date
: 08-May-2026
NAV [Rs.]
: 30.8654
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: 1.00% For exit within 12 months from the date of allotment. Nil - For exit after 12 months from the date of allotment.
LIC MF Healthcare Fund Regular IDCW- NAV Chart
LIC MF Healthcare Fund Regular IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 4.49 | 12.83 | 10.59 | 3.07 | 10.54 | 22.74 | 11.13 | 16.85 |
| Category Avg | 3.99 | 11.34 | 10.43 | 5.17 | 11.86 | 25.24 | 14.75 | 14.97 |
| Category Best | 5.89 | 13.07 | 13.61 | 10.49 | 20.68 | 29.69 | 17.5 | 29.71 |
| Category Worst | 2.9 | 8.89 | 7.05 | 0.94 | 5.13 | 20.97 | 11.14 | -1.62 |
LIC MF Healthcare Fund Regular IDCW- Latest Dividends
No Records Found
LIC MF Healthcare Fund Regular IDCW- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 500
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 11.22 | 52436 | 9.48 |
| Equity | Apollo Hospitals | Healthcare Services | 6.52 | 7217 | 5.51 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 6.50 | 13130 | 5.49 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 5.15 | 31301 | 4.34 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 4.74 | 6158 | 4.00 |
| Equity | Fortis Health. | Healthcare Services | 4.70 | 43032 | 3.97 |
| Equity | Neuland Labs. | Pharmaceuticals & Biotechnology | 4.59 | 2585 | 3.87 |
| Equity | OneSource Speci. | Pharmaceuticals & Biotechnology | 4.56 | 22159 | 3.85 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 4.33 | 226088 | 3.65 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.41 | 11994 | 2.88 |
| Equity | Navin Fluo.Intl. | Chemicals & Petrochemicals | 3.32 | 4116 | 2.80 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.20 | 5008 | 2.70 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 3.03 | 19567 | 2.56 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 3.01 | 16604 | 2.54 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.91 | 968 | 2.46 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.91 | 14043 | 2.45 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 2.77 | 20531 | 2.34 |
| Equity | Artemis Medicare | Healthcare Services | 2.70 | 93529 | 2.28 |
| Equity | Metropolis Healt | Healthcare Services | 2.67 | 47304 | 2.25 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.28 | 8577 | 1.92 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 2.28 | 25333 | 1.92 |
| Equity | Dr Agarwal's Hea | Healthcare Services | 2.08 | 39576 | 1.76 |
| Equity | Global Health | Healthcare Services | 1.98 | 14952 | 1.67 |
| Equity | Max Healthcare | Healthcare Services | 1.97 | 16775 | 1.66 |
| Equity | Acutaas Chemical | Pharmaceuticals & Biotechnology | 1.93 | 6296 | 1.63 |
| Equity | Vinati Organics | Chemicals & Petrochemicals | 1.37 | 8741 | 1.15 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
LIC Mutual Fund
Incorporation Date:
20-Apr-1994
Total Assets Managed (Cr.):
47,207.09
Trustee/s:
Mr. Pradeep Jagannath Bhi, LIC Mutual Fund Trustee P
Chairman:
NA
CEO / MD:
T.S. Ramakrishnan, Ravi Kumar Jha
CIO:
NA
President:
NA
Director/s:
Raghunandan Maluste, Vijay Sharma, Sanjay Achyutrao Muthal, Praveen Garg
Compliance Officer/s:
NA
Investor Service Officer/s:
Srividya Baliga
Fund Manager/s:
Sudhanshu Asthana
Auditors:
S.R. Batliboi LLP
OTHER INFORMATION
Registered Office:
4th Floor, Industrial Insurance Building, Opp.Churchgate Stati Mumbai 400 020.
Contact Nos:
022-66016000
Fax:
022-22843660
Email:
Website:
